Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke

NCT: NCT06170944 · RECRUITING

NCT IDNCT06170944
StatusRECRUITING
Start Date2024-06-01
Completion2027-11-30

Brief Summary

The goal of this clinical trial is to explore the influence of chronic RIC on collateral status evaluated by DSA in ischemic stroke patients with LAA etiology.

Frequently Asked Questions

What is Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke?

Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke is a clinical trial registered under NCT06170944. Current status: RECRUITING.

What is the status of NCT06170944?

The current status of NCT06170944 (Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke) is: RECRUITING.

When did Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke start?

Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke started on 2024-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑